Cargando…
Current safety preferences for intravitreal injection during COVID-19 pandemic
Autores principales: | Shmueli, Or, Chowers, Itay, Levy, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197242/ https://www.ncbi.nlm.nih.gov/pubmed/32366999 http://dx.doi.org/10.1038/s41433-020-0925-x |
Ejemplares similares
-
Hybrid Telehealth Medical Retina Clinic Due to Provider Exposure and Quarantine During COVID-19 Pandemic
por: Aweidah, Hamzah, et al.
Publicado: (2020) -
The detrimental effects of delayed intravitreal anti-VEGF therapy for treating retinal pathology: lessons from a forced test-case
por: Navarrete, Ana, et al.
Publicado: (2022) -
Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic
por: Pfeiler, Georg, et al.
Publicado: (2022) -
Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations
por: Tan, A. C. S., et al.
Publicado: (2022) -
Risk of SARS-CoV-2 transmission to medical staff and patients from an exposure to a COVID-19-positive ophthalmologist
por: Saban, Ori, et al.
Publicado: (2020)